Company intelligence / Profile preview
Peaches Biotech
Madrid, Madrid, Spainpeaches.es ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Peaches Biotech is developing innovative therapies based on advanced cell therapies, including cytokines, stem cells, and T-lymphocytes. Their secretome platform is designed to produce drugs that mimic the regenerative signals from stem cells.
- Therapeutic areas
- NeurologyOncologyOtherImmunologyRheumatology
- Modalities
- Cell therapyCytokine therapyStem cell therapyT cell therapy
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
University Hospital of FuenlabradaHarvard Medical School
Beyond the preview
Go deeper on Peaches Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Peaches Biotech.